Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SOCS6 pseudogene 1 (SOCS6P1) is classified as a pseudogene related to the suppressor of cytokine signaling 6 (SOCS6) gene, which means it resembles the functional SOCS6 gene but does not produce a functional protein and is generally considered non-coding. The functional SOCS6 protein is part of the SOCS family of negative regulators of cytokine signaling, but no biological activity, disease role, or drug interaction has been attributed specifically to SOCS6P1. Experimental studies have not detected transcripts from the SOCS6 pseudogene locus, suggesting it is nonfunctional[1]. Thus, SOCS6P1 does not represent a valid therapeutic target, receptor, enzyme, or signaling protein. The query may confound the functional gene SOCS6 (a protein-coding gene with relevance in cytokine signaling, negative regulation, and cancer biomarker studies[4][7]) with the SOCS6 pseudogene 1, which is a nonfunctional sequence and not a direct molecular target. Pseudogenes, in some cases, may be transcribed and involved in post-transcriptional regulatory networks, but there is no evidence in the literature or databases that SOCS6P1 functions in this capacity[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SOCS6 pseudogene 1 (SOCS6P1).